Rare Diseases – Talk Bio

Actionable Insights Powered by AI

Diagonal Therapeutics Secures $128 Million Series A Funding through Innovative Antibody Agonists

Diagonal Therapeutics, Series A funding, Antibody agonism, Cellular “on” switches, Rare diseases